A Phase 2, Randomized, Double-blind, Placebo Controlled Dose Ranging Study of Repeat Doses of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy

Clinical trial NCT01987986 · COMPLETED

Trial details

NCT number

NCT01987986

Sponsor

Endo USA Inc., a Keenova Therapeutics Company

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2013-10-01

Primary completion

2014-08-01

Enrollment

150

View on ClinicalTrials.gov